Research Topics
Genomes and Genes | anus neoplasmsSummarySummary: Tumors or cancer of the ANAL CANAL. Top Publications
Research Grants
| Scientific Experts
|
Detail Information
Publications
Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virusFrancine Walker
Department of Pathology, Institut de la Santé et de la Recherche Médicale Unité773, Hopital Bichat Claude Bernard, 75018 Paris, France
Hum Pathol 40:1517-27. 2009..The finding that EGFR, c-Met, and VEGFR1 involved in carcinogenesis are well-represented and coexpressed in anal cancers, especially in HIV-positive population, suggests possible novel targeted treatments for anal diseases...
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trialJaffer A Ajani
Department of Gastrointestinal Medical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Mail Stop 426, Houston, Texas 77030, USA
JAMA 299:1914-21. 2008..Chemoradiation as definitive therapy is the preferred primary therapy for patients with anal canal carcinoma; however, the 5-year disease-free survival rate from concurrent fluorouracil/mitomycin and radiation is only approximately 65%...
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysisHugo De Vuyst
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Int J Cancer 124:1626-36. 2009..This proportion would be similar for the corresponding high-grade lesions of the vagina and anus, but higher for VIN2/3 (75%) than for vulvar carcinoma...
Anal cancer: the end of the road for neoadjuvant chemoradiotherapy?Rob Glynne-Jones
Mount Vernon Cancer Centre, Northwood, Middlesex, United Kingdom
J Clin Oncol 26:3669-71. 2008
The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapyD C Weber
Radiation Oncology Department of the University Hospital, Geneva, Switzerland
Int J Radiat Oncol Biol Phys 50:675-80. 2001..The present analysis suggests that shortening the gap contributes to optimizing LRC. Gaps longer than 5 weeks correlated with poorer LRC, with especially unsatisfactory results observed in younger patients...
High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II studyD Peiffert
Centre Alexis Vautrin, Nancy, France
Ann Oncol 12:397-404. 2001..To analyse toxicity and response to a new scheme of neoadjuvant chemotherapy (CT) and concomitant radiochemotherapy (RT-CT) for locally advanced anal canal squamous-cell carcinoma (ACC)...
Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014)O Matzinger
EORTC Headquarters, Brussels, Belgium
Eur J Cancer 45:2782-91. 2009..To assess the feasibility and activity of radio-chemotherapy with mitomycin C (MMC) and cisplatin (CDDP) in locally advanced squamous cell anal carcinoma with reference to radiotherapy (RT) combined with MMC and fluorouracil (5-FU)...
Human papillomavirus type distribution in anal cancer and anal intraepithelial lesionsBrooke E Hoots
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599 7400, USA
Int J Cancer 124:2375-83. 2009..If ongoing clinical trials show efficacy in preventing anal HPV infection and associated anal lesions, prophylactic HPV vaccines may play an important role for the primary prevention of these cancers in both genders...
ACT II: the second UK phase III anal cancer trialR James
Clin Oncol (R Coll Radiol) 17:364-6. 2005
Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and GastroH Bartelink
Department of Radiotherapy, The Netherlands Cancer Institute Antoni van Leeuwenhoek Huis, Amsterdam, The Netherlands
J Clin Oncol 15:2040-9. 1997....
Low acute toxicity of radiotherapy and radiochemotherapy in patients with cancer of the anal canal and HIV-infectionS Hocht
Abteilung Strahlentherapie, Universitätsklinikum Benjamin Franklin der Freien Universität Berlin, Germany
Acta Oncol 36:799-802. 1997..No excessive acute reactions were seen. Because of the short follow-up, late reactions and local control are not yet evaluable...
Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup studyM Flam
University of California, San Francisco, Fresno, USA
J Clin Oncol 14:2527-39. 1996....
Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapyRobert P Akbari
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Dis Colon Rectum 47:1136-44. 2004..persistence) after chemoradiation (when salvage is potentially curative), absence of nodal disease at salvage, and negative margins. Salvage inguinal lymph node dissection after failed chemoradiation therapy also is potentially curative...
Smoking-related DNA adducts in anal epitheliumDavid H Phillips
Institute of Cancer Research, Brookes Lawley Building, Cotswold Road, Sutton SM2 5NG, UK
Mutat Res 560:167-72. 2004..00001, Fisher's exact test). These results indicate that components of tobacco smoke inflict genotoxic damage in the anal epithelium of smokers and provide a plausible mechanism for a causal association between smoking and anal cancer...
[Anorectal melanoma. A rare and highly malignant tumor entity of the anal canal]B M Helmke
Pathologisches Institut, Universitat Heidelberg
Pathologe 25:171-7. 2004..The poor long-term prognosis of anorectal melanomas correlates with their advanced tumor size and depth of infiltration at diagnosis. The overall 5-year survival rates range between <5 and 22% in different series...
Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancerJulie K Schwarz
Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
Int J Radiat Oncol Biol Phys 71:180-6. 2008..To evaluate the response to therapy for anal carcinoma using post-therapy imaging with positron emission tomography (PET)/computed tomography and F-18 fluorodeoxyglucose (FDG) and to compare the metabolic response with patient outcome...
Cancer of the anal canalMatthew A Clark
Department of General Surgery, Middlemore Hospital, Otahuhu, Auckland, New Zealand
Lancet Oncol 5:149-57. 2004..Future challenges will be influenced by an increasing incidence due to human papillomavirus and HIV infection, more accurate characterisation and treatment of early (in situ) disease, and optimisation of chemoradiation regimens...
[Radiotherapy of carcinomas of the anal canal. Tenon Hospital experience]E Touboul
service d oncologie radiothérapie, Hopital Tenon, AP HP, 4, rue de la Chine, 75020 Paris, France
Cancer Radiother 7:91s-99s. 2003..We report the Tenon hospital experience since 1972 concerning the long term results after radiation therapy, the modifications of the radiation technique, and the evolution of treatment strategy...
Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer NetworkYazid Belkacemi
Radiation Therapy, Oscar Lambret Center, Lille, France
Int J Radiat Oncol Biol Phys 56:1274-83. 2003..The current standard treatment consists of abdominoperineal resection (APR). The aim of this Rare Cancer Network study was to evaluate the prognostic factors and outcome after the three most commonly used treatment approaches...
Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapyLoren K Mell
Department of Radiation and Cellular Oncology, University of Chicago and University of Illinois at Chicago, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 70:1431-7. 2008....
Lymphatic mapping and sentinel lymph node biopsy in epidermoid carcinoma of the anal canalS Gretschel
Department of Surgery and Surgical Oncology, Charite, Universitatsmedizin Berlin, Campus Buch, Robert Rossle Klinik, HELIOS Klinikum Berlin, Berlin, Germany
Eur J Surg Oncol 34:890-4. 2008..Inguinal sentinel lymph node biopsy (SLNB) can be used to select patients appropriately for inguinal radiation. The study evaluates the efficiency and clinical impact of SLNB...
Gastrointestinal stromal tumor of the anusG Y M Tan
Department of Colorectal Surgery, Singapore General Hospital, Singapore
Tech Coloproctol 7:169-72. 2003..Oncologic resection and protracted follow-up must factor in their predilection for late recurrence and metastatic spread. The role of adjuvant therapy with STI571 here remains to be clearly defined...
Carcinoma of the anal canal: a local experience and review of the literatureShirley Wong
Department of Medical Oncology, Royal Melbourne Hospital, Victoria, Australia
ANZ J Surg 74:541-6. 2004..The aim of the present study is to determine how widely the combined modality approach has been adopted in routine clinical practice and what outcomes are achieved in this setting...
Anorectal amelanotic melanomaA Hillenbrand
Department of General, Visceral, and Transplantation Surgery, University of Ulm, Ulm, Germany
Colorectal Dis 10:612-5. 2008..Anorectal melanoma is a rare, highly malignant tumour with a poor 5 year survival of 10%. Most anorectal melanomas have gross and/or histologic pigmentation, however about 30% of anorectal melanomas are amelanotic...
Surgical management of primary anorectal melanomaP Pessaux
Department of Surgery, Comprehensive Cancer Centre, Institut Gustave Roussy, Villejuif, France
Br J Surg 91:1183-7. 2004..CONCLUSION: Anorectal melanoma is a rare disease with a poor prognosis. Wide local excision is recommended as primary therapy if negative resection margins can be achieved...
FDG-PET/CT in the evaluation of anal carcinomaShane E Cotter
Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA
Int J Radiat Oncol Biol Phys 65:720-5. 2006..FDG-PET/CT detects substantially more abnormal inguinal lymph nodes than are identified by standard clinical staging with CT and physical examination...
Expression of epidermal growth factor receptor in squamous cell carcinomas of the anal canal is independent of gene amplificationGustavo Alvarez
Lauren V Ackerman Laboratory of Surgical Pathology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110-1093, USA
Mod Pathol 19:942-9. 2006..These observations may have important therapeutic implications since EGFR-based targeted therapies have shown promise for other malignant neoplasms...
Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcomeMichael T Milano
Department of Radiation and Cellular Oncology, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 63:354-61. 2005..Compared with historical controls, local control is not compromised despite efforts to increase conformality and reduce normal structure dose...
[Anal cancer in Iceland 1987-2003. A population based study]Halla Vietharsdóttir
Department of Surgery, Iceland University Hospital, Hringbraut, 101 Reykjavik, Iceland
Laeknabladid 92:365-72. 2006..Anal cancer is a rare disease. The aim of this study was to describe anal cancer in Iceland in 1987-2003 with respect to incidence, histologic type, treatment, recurrence rate and survival...
Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canalThomas G Trautmann
Southeast Radiation Oncology, Charlotte, NC, USA
Mol Imaging Biol 7:309-13. 2005..We investigated the utility of positron emission tomography (PET) with 2-deoxy-2[F-18]fluoro-D-glucose (FDG) in the staging and determination of response to CMT...
Factors affecting survival in patients with anal melanomaYale D Podnos
Department of General Oncologic Surgery, City of Hope National Medical Center, Duarte, California 91010, USA
Am Surg 72:917-20. 2006..Anal melanoma remains an uncommon but lethal disease. Extent of disease correlates with overall survival. Survival is improving, but the use and extent of operation are not associated with improved overall survival...
Response of stage IV anal mucosal melanoma to chemotherapyJen Jen Yeh
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Lancet Oncol 6:438-9. 2005
Wide local excision or abdominoperineal resection as the initial treatment for anorectal melanoma?John T Droesch
Department of Surgery, University of Washington, 1959 N E Pacific St, Box 356410, Seattle, WA 98195 6410, USA
Am J Surg 189:446-9. 2005..Anorectal melanoma (AM) is a rare tumor with a poor prognosis. Treatment with abdominoperineal resection (APR) over wide local excision (WLE) is still debated. This study aimed to compare median survival of WLE and APR in patients with AM...
Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapyTe Vuong
Department of Radiation Oncology, McGill University Health Centre, Quebec, Canada
Int J Radiat Oncol Biol Phys 67:1394-400. 2007....
Chemoradiotherapy in patients with anal cancer: impact of length of unplanned treatment interruption on outcomeAndreas Meyer
Department of Radiation Oncology, Medical School Hannover, Hannover, Germany
Acta Oncol 45:728-35. 2006..762), respectively. Chemoradiotherapy with short individualised treatment interruptions seems to be feasible with acceptable acute or late toxicities. Treatment is highly effective in terms of local control and colostomy-free survival...
Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocolsPer J Nilsson
Centre of Gastrointestinal Disease, Ersta Hospital, Stockholm, Sweden
Int J Radiat Oncol Biol Phys 61:92-102. 2005..The use of neoadjuvant chemotherapy has been infrequently reported in the literature. This study presents results from a large population-based series and provides comparisons between different treatments...
Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experienceJoseph K Salama
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
J Clin Oncol 25:4581-6. 2007..To report a multicenter experience treating anal canal cancer patients with concurrent chemotherapy and intensity-modulated radiation therapy (IMRT)...
Impact of overall treatment time on local control of anal cancer treated with radiochemotherapyR Graf
Center of Radiation Medicine, Campus Virchow Clinic, , Humboldt University, Berlin, Germany
Oncology 65:14-22. 2003....
Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II studyTe Vuong
Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada
Int J Radiat Oncol Biol Phys 56:823-31. 2003..To evaluate the feasibility of delivering conformal radiotherapy (RT) and concurrent chemotherapy without a mandatory break in patients with anal canal carcinoma...
Carcinoma of the anus: strategies in managementNatia Esiashvili
Emory University School of Medicine, Department of Radiation Oncology, Atlanta, Georgia, USA
Oncologist 7:188-99. 2002..Ongoing studies attempt to define an optimal treatment regimen that yields a higher cure rate while minimizing toxicity. We review the etiology, epidemiology, and treatment regimens for anal cancer...
Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational statusNadine Lukan
III Medizinische Klinik, Universitatsmedizin Mannheim, Mannheim, Deutschland
Oncology 77:293-9. 2009..Anal cancers universally express the epidermal growth factor receptor (EGFR) and KRAS mutations have not been reported in anal cancer thus far...
Biochemotherapy in patients with metastatic anorectal mucosal melanomaKevin B Kim
Department of Melanoma Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston Texas 77030, USA
Cancer 100:1478-83. 2004..Patients with metastatic anorectal melanoma generally have an unfavorable prognosis, but no effective systemic therapy has been reported...
Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvementJoseph C Hodges
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 75:791-4. 2009....
A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapyKiran Devisetty
Department of Radiation and Cellular Oncology, University of Chicago, IL, USA
Radiother Oncol 93:298-301. 2009..For V(30)>450 cc and < or =450 cc, acute GI toxicity was 33% and 8%, respectively (p=0.003)...
Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcomeR J Myerson
Radiation Oncology Center, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
Radiother Oncol 61:15-22. 2001..Because of the occurrence of additional malignancy, patients with anal cancer should receive general oncologic screening in long-term follow-up...
The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancerE de Winton
Department of Oncology, Royal United Hospital, Bath, UK
Br J Cancer 100:693-700. 2009..9%) and 55.3% (95% CI: 23.3-83.4%), respectively. FDG-PET shows increased sensitivity over CIm for staging nodal disease in anal cancer and changes treatment intent or radiotherapy prescription in a significant proportion of patients...
The evolving treatment of anal cancer: How are we doing?M H Whiteford
Department of Surgery, Oregon Health Sciences University, Portland, OR, USA
Arch Surg 136:886-91. 2001..The adaptation of new techniques in treatment of epidermoid carcinoma of the anal canal during the past 3 decades has improved clinical outcomes...
Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapyA S Allal
Division of Radiation Oncology, University Hospital of Geneva, Switzerland
Br J Cancer 80:1588-94. 1999..Moreover, the subset of patients who presented with severe complications and/or anal dysfunction showed poorer scores in most scales...
Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individualsI Sobhani
Department of Coloproctology, Hopital Bichat Claude Bernard, Paris, France
Gastroenterology 120:857-66. 2001..We determined the prevalence of anal dysplasia and cancer in patients with anal canal condyloma with respect to human immunodeficiency virus (HIV) status, immunity status, and human papillomavirus types...
Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literatureJ P Gerard
Department of Radiotherapy Oncology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France
Cancer 92:77-84. 2001....
Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?Sabine Kathrin Mai
Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Germany
Strahlenther Onkol 185:254-9. 2009..To investigate whether a dose reduction to CT-enlarged but FDG-PET-negative (([(18)F]-fluoro-2-deoxy-D-glucose positron emission tomography) inguinal lymph nodes in radiochemotherapy of anal cancer is safe...
Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective studyT Bjørge
Department of Pathology, The Norwegian Radium Hospital, 0310 Oslo, Norway
Br J Cancer 87:61-4. 2002..This study provides prospective epidemiological evidence of an association between infection with HPV 16 and 18 and anal and perianal skin cancer...
Successful palliation of stenosing anorectal melanoma by intratumoral injections with natural interferon-betaA Ulmer
, , Liebermeisterstr. 25, , Germany
Melanoma Res 12:395-8. 2002....
Surgical treatment for anorectal malignant melanoma: report of five cases and review of 79 Japanese casesSatoshi Ishizone
Department of Surgery, Shinshu University School of Medicine, 3 1 1 Asahi, Matsumoto, 390 8621, Japan
Int J Colorectal Dis 23:1257-62. 2008..We also review the present five cases along with 74 other Japanese cases reported between 1997 and 2006 and discuss the role of surgery in the treatment of AMM...
Screening for anal dysplasia associated with human papillomavirusWm Christopher Mathews
University of California San Diego Medical Center, USA
Top HIV Med 11:45-9. 2003..This article summarizes a presentation given by Wm. Christopher Mathews, MD, MSPH, at the November 2002 International AIDS Society-USA course in San Diego...
Assessing the impact of FDG-PET in the management of anal cancerBrandon T Nguyen
Radiation Oncology Centre, Austin Health, Vic, Australia
Radiother Oncol 87:376-82. 2008..To assess the utility of FDG-PET in anal cancer for staging and impact on radiotherapy planning (RTP), response and detection of recurrent disease...
Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and GastrJ F Bosset
Radiotherapy Department, Besancon University Hospital, Besancon, France
Eur J Cancer 39:45-51. 2003..The 22953 scheme is feasible and the results are promising. This is now considered as the new standard scheme by the EORTC...
Performance of anal cytology in a clinical setting when measured against histology and high-resolution anoscopy findingsMayura Nathan
Department of Sexual Health, Homerton University Hospital NHS Foundation Trust, London E9 6SR, UK
AIDS 24:373-9. 2010..The success of cervical cytology in screening for cervical neoplasia has led to the concept of anal cytology screening for anal neoplasia. Our objective is to study the performance of anal cytology as a screening tool...
Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism?M Frisch
Department of Epidemiology Research, Danish Epidemiology Science Center, Statens Serum Institut, Copenhagen
J Natl Cancer Inst 91:708-15. 1999..Smoking was recently suggested to increase the risk of anal cancer more in premenopausal women than in postmenopausal women. Thus, we used our population-based anal cancer case-control study in Denmark and Sweden to test this hypothesis...
Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virusPeter V Chin-Hong
Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA 94143 0512, USA
Clin Infect Dis 35:1127-34. 2002..Treatment for AIN remains challenging, but AIN is easier to treat when the lesions are small, and it is likely that a screening program would identify affected individuals at an earlier stage of disease...
Long-term outcome after combined radiochemotherapy for anal cancer - retrospective analysis of efficacy, prognostic factors, and toxicitySabine K Mai
Department of Radiation Oncology, University Medical Center Mannheim, Germany
Onkologie 31:251-7. 2008..This retrospective study evaluated the efficacy, prognostic factors, and toxicity of combined radiochemotherapy for anal cancer...
Sentinel lymph node biopsy for squamous cell carcinoma of the anal canalPhilippa Rabbitt
University of Adelaide Department of Surgery, The Queen Elizabeth Hospital, South Australia, Australia
ANZ J Surg 72:651-4. 2002..The fourth patient had a sentinel node mapped to a meso-rectal node. This was not sampled. CONCLUSIONS: The application of this effective technique will allow accurate staging of anal cancers to better plan future treatment regimes...
Management of anal cancer in the HIV-positive populationJohn Kauh
Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
Oncology (Williston Park) 19:1634-8; discussion 1638-40, 1645 passim. 2005..Continued studies and phase III trials will be needed to test new treatment strategies in HIV-infected patients with squamous cell cancer of the anus to determine which treatment protocols provide the greatest benefits...
Cutaneous malignancy and human immunodeficiency virus diseaseKarl Wilkins
Department of Dermatology, University of California San Francisco, California, USA
J Am Acad Dermatol 54:189-206; quiz 207-10. 2006..LEARNING OBJECTIVE: At the completion of this learning activity, participants should be familiar with the unique epidemiology, clinical course, and management of cutaneous malignancy in patients infected with HIV...
Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicitiesScott Edelman
Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
Int J Radiat Oncol Biol Phys 66:206-11. 2006..We report toxicity and survival data of human immunodeficiency virus (HIV)-infected men with anal carcinoma treated with combined modality therapy (CMT) of radiotherapy and concurrent chemotherapy...
Anus-preservation treatment for anal cancer: retrospective analysis at a single institutionYi Wei Chen
Cancer Center, Taipei Veterans General Hospital and Institute of Clinical Medicine, National Yang Ming University, Taipei, Taiwan, Republic of China
J Surg Oncol 96:374-80. 2007..To evaluate anus-preservation treatment for anal cancer...
The bottom line: outcomes after conservation treatment in anal cancerM K Dwyer
Department of Radiation Oncology, Westmead Hospital, Westmead, North South Wales, Australia
Australas Radiol 50:46-51. 2006..Most patients with anal cancer can expect to retain a functional sphincter after chemoradiation/radiation. Further studies are in progress to determine the optimal chemoradiation protocol...
[Challenging conversation with a patient about the change in treatment strategy from a curative to a palliative setting]Heinrich Kiss
Interne Abteilung mit Palliativstation, Krankenhaus Oberwart, Osterreich
Wien Med Wochenschr 156:324-6. 2006..This case shows the typical problems of a physician-patient relationship in an oncologic clinic and emphasizes the importance of integrating medical with psychosocial care...
Anal cancer: current and future methodologyCathy Eng
University of Texas MD Anderson Cancer Center, Department of Gastrointestinal Medical Oncology, Houston, TX 77030, USA
Cancer Invest 24:535-44. 2006..Novel approaches currently are underway in this select patient population and will be addressed for the purposes of this manuscript...
Lipodermatosclerosis as a form of vascular compromise-associated radiation recall dermatitis: case report and a review of literatureNovie Sroa
College of Medicine and Public Health, Ohio State Universitym Columbus, Ohio, USA
J Cutan Pathol 33:55-9. 2006..This is the first case providing evidence of the causative role of 5-fluorouracil and cisplatin in potentially inducing RRD...
Squamous-cell carcinoma of the anal canal: predictors of treatment outcomeRamin Roohipour
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Dis Colon Rectum 51:147-53. 2008..The incidence of anal canal squamous-cell carcinoma is increasing. Limited data exist on predictors of treatment failure. This study was designed to identify predictors for relapse/persistence after first-line therapy...
EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancerRob Glynne-Jones
Mount Vernon Cancer Centre, Mount Vernon Hospital, Middlesex, United Kingdom
Int J Radiat Oncol Biol Phys 72:119-26. 2008..This phase II trial aimed to determine the feasibility, toxicity, and efficacy of capecitabine, MMC and radiotherapy (RT) in anal cancer patients...
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281)Neal J Meropol
Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111, USA
J Clin Oncol 26:3229-34. 2008....
Anal human papillomavirus testing with Digene's hybrid capture 2 using two different sampling methodsFlorian Roka
Department of Dermatology, Division of General Dermatology, Medical University Vienna, Waehringer Guertel 1820, Vienna, Austria
Dis Colon Rectum 51:62-6. 2008..The purpose of this study was to determine the usefulness of a human papillomavirus-DNA detection test to detect human papillomavirus-associated disease and to compare two different methods of sample collection...
Familial clustering of cancer at human papillomavirus-associated sites according to the Swedish Family-Cancer DatabaseShehnaz K Hussain
Center for Family and Community Medicine, Karolinska Institute, Huddinge, Sweden
Int J Cancer 122:1873-8. 2008..These data suggest that common host factors exist among individuals affected with anogenital and upper aerodigestive tract cancers...
Prevalence status and association with human papilloma virus of anal squamous proliferative lesions in a patient sample in TaiwanTsen Fang Tsai
Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
Sex Transm Dis 35:721-4. 2008..The objectives of the study were to investigate the HPV prevalence of anal squamous proliferative lesion in Taiwan...
Activation of AKT and nuclear accumulation of wild type TP53 and MDM2 in anal squamous cell carcinomaHeena Patel
Colorectal Cancer Genetics, Institute for Cell and Molecular Sciences, Blizard Building, Barts and The London, Queen Mary s School of Medicine and Dentistry, 4 Newark St, Whitechapel E1 2AT, United Kingdom
Int J Cancer 121:2668-73. 2007..04, p = 0.01, respectively). We propose that activation of AKT, possibly through the PI3K-AKT pathway, is an important component of ASCC tumorigenesis that contributes to MDM2 and TP53 accumulation in the nucleus...
Anal intraepithelial neoplasia and anal cancer in dermatological practiceAsoka Herat
Skin and Cancer Foundation, Darlinghurst, New South Wales, Australia
Australas J Dermatol 48:143-53; quiz 154-5. 2007..In view of recent developments in the understanding of this condition, this article reviews the current understanding of anal intraepithelial neoplasia and its treatment from a dermatological perspective...
Outcomes of salvage surgery for squamous cell carcinoma of the anal canalDan E Schiller
Department of Surgery, Mount Sinai Hospital, University of Toronto, Suite 1224, 600 University Avenue, M5G 1X5, Toronto, Ontario, Canada
Ann Surg Oncol 14:2780-9. 2007..The literature regarding SS is limited by small patient numbers and/or heterogeneous treatment protocols. We report on a large series of patients initially treated with chemoradiation at a major referral center...
Combined surgery and chemoradiation as a treatment for the Buschke-Löwenstein tumourM G Tytherleigh
Department of Surgery, Wexham Park Hospital, Slough, Berkshire, SL2 4HL, UK
Surgeon 4:378-83. 2006..Chemoradiation remains the mainstay of treatment for anal cancers but has not been routinely employed in the management of the BLT without squamous cell carcinoma transformation...
[Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)]E Deniaud-Alexandre
, , APHP, 4, rue de la Chine, 75970 Paris Cedex 20, France
Cancer Radiother 10:572-82. 2006..For patients with T3 or T4 lesion and tumor regression <or=50% after the first course of radiation therapy, surgical non conservative treatment should be discussed...
Human papillomavirus (HPV), DNA aberrations and cell cycle progression in anal squamous cell carcinoma patientsNongnit Laytragoon-Lewin
Department of Oncology, Rudbeck Laboratory, Uppsala University Hospital, Sweden
Anticancer Res 27:4473-9. 2007..Human papillomavirus (HPV) infections of the genital tract are sexually transmitted and prevalent worldwide. In this study, the role of HPV in 72 patients with anal squamous cell carcinoma was investigated...
[Malignant transformation of perianal Buschke-Löwenstein tumor. Extensive abdominoperineal rectum excision and reconstruction with transpelvic myocutaneous rectus abdominis muscle flap]R Dolanc
Departement Chirurgie, Kantonsspital, 4600 Olten, Schweiz
Chirurg 73:370-4. 2002..Although of histologically benign appearance, it infiltrates and destroys the surrounding tissue. There is a high risk of local recurrence and malignant transformation. The treatment of choice is wide surgical resection...
Effect of anal epidermoid cancer-related viruses on the dendritic (Langerhans') cells of the human anal mucosaIradj Sobhani
Department of Gastroenterology and Oncology, Hopital Bichat Claude Bernard, Paris, France
Clin Cancer Res 8:2862-9. 2002..The incidence of anal cancer is high in patients with anal condyloma. HIV increases this risk. We analyzed anal mucosa from normal individuals and individuals with condyloma...
Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapyCecile Ortholan
Department of Radiation Oncology, Centre Antoine Lacassagne, Nice, France
Int J Radiat Oncol Biol Phys 62:479-85. 2005..To investigate the clinical history, management, and pattern of recurrence of very early-stage anal canal cancer in a French retrospective survey...
Induction chemotherapy followed by radiotherapy in the treatment of anal cancerDae Ho Lee
Department of Internal Medicine, Seoul National University College of Medicine, Korea
Oncol Rep 10:101-4. 2003..Induction chemotherapy followed by radiotherapy in patients with anal cancer is effective in terms of its response and preserving the anal sphincter without serious acute and late complications...
[Prognosis of epidermoid anal carcinoma regression after conservative treatment]T S Odariuk
Vopr Onkol 50:663-7. 2004..015). ERUS uTNM staging is more effective in prognosis for RT and CRT and, therefore, should be recommended for preliminary management of epidermoid anal carcinoma...
Chemoradiation for adenocarcinoma of the anusMichael Papagikos
Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
Int J Radiat Oncol Biol Phys 55:669-78. 2003....
Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic indexArthur Hung
Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston 77030, USA
Cancer 97:1195-202. 2003..These rates are comparable to the best results reported with mitomycin-C and 5-FU. Without the normally severe toxicity, cisplatin-based therapy results in a wider therapeutic index...
Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectivenessRobson Ferrigno
Department of Radiation Oncology, , , Brazil
Int J Radiat Oncol Biol Phys 61:1136-42. 2005..Local control was higher in patients treated with doses of more than 50 Gy at primary tumor. The high incidence of inguinal failure implies the need for elective RT in this region...
Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNADanielle W Lu
Lauren V. Ackerman Laboratory of Surgical Pathology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, USA
Mod Pathol 16:692-9. 2003....
Spectrum of human papillomavirus-related dysplasia and carcinoma of the anus in HIV-infected patientsLori A Panther
Department of Internal Medicine, Division of Infectious Diseases, Harvard Medical School, Boston, Massachusetts, USA
AIDS Read 15:79-82, 85-6, 88, 91. 2005..All HIV-positive patients with invasive cancer of the anal canal, particularly those with CD4+ cell counts greater than 200/microL and those receiving HAART, should be managed in the same manner as their HIV-negative counterparts...
[Perianal Bowen's disease: a case report and review of the literature]A Bertagni
UO di Chirurgia Generale II, , Ospedale GB Morgagni-L Pierantoni, Forl
Tumori 89:16-8. 2003..We report a case of a 50-years-old woman with recurrence of Bowen's disease associated with vulvar HPV infection and review the literature...
[Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients]E Deniaud-Alexandre
, , 4, rue de la-Chine, 75020 Cedex 20, Paris, France
Cancer Radiother 7:237-53. 2003..However, chemoradiotherapy should be prefered to improve survival free of colostomy with a good anal sphincter function for tumors more than or equal to 2 cm in length and locally advanced tumors...
Treatment of relapsing anal carcinomaG Tanum
Department of Oncology, Norwegian Radium Hospital, Oslo
Acta Oncol 32:33-5. 1993..An abdominoperineal resection was performed on 9 of the 11 patients with local relapse. Of these, 6 patients were alive without evident disease after 3 years of observation...
Risk factors associated with requiring a stoma for the management of anal cancerWyn D Nguyen
Department of Colon and Rectal Surgery, Baylor University Medical Center, Dallas, Texas, USA
Dis Colon Rectum 47:843-6. 2004..Toxicities from chemoradiotherapy do arise, but patients are not at increased risk for requiring a stoma...
[Effectiveness of chemoradiotherapy for three cases of squamous cell anal carcinoma]Atsushi Takeno
Dept. of Surgery, National Hospital Organization Osaka National Hospital
Gan To Kagaku Ryoho 31:1870-2. 2004..The prognosis of anal squamous cell carcinoma that received Cur B or C resection was extremely poor with a median survival time (MST) of 7 or 6 months. Chemoradiotherapy seems to be effective as the first line treatment...
[Rationale and progress of the phase III trial: intensification of the treatment of locally advanced squamous cell carcinoma of the anal canal]D Peiffert
Centre Alexis Vautrin, 6, Avenue de Bourgogne, 54511 Vandaeuvre les Nancy, France
Cancer Radiother 7:100s-107s. 2003..The results of the 101 first included patients are studied by an intermediate analyze. In July 2003, 222 patients were enrolled by 33 investigating centres out of the 350 planned patients until the end of the trial in December 2004...
Bilateral leg amputation following chemoradiation for squamous carcinoma of the anusTamasin K A Evans
Radiother Oncol 73:110-1. 2004
Neoadjuvant chemotherapy followed by radiotherapy in epidermoid carcinoma of anusEui Kyu Chie
Department of Therapeutic Radiology, Seoul National University College of Medicine, Korea
Tumori 90:299-302. 2004..CONCLUSIONS: Neoadjuvant chemotherapy with a cisplatin-based regimen rather than concurrent regimen plus radiotherapy may decrease complications without compromising survival or sphincter preservation...
Activity of HspE7, a novel immunotherapy, in patients with anogenital wartsStephen E Goldstone
Mount Sinai School of Medicine, New York, New York, USA
Dis Colon Rectum 45:502-7. 2002..The warts improved substantially but usually did not totally disappear within six months. Patient follow-up continues. A new randomized, placebo-controlled trial is underway to evaluate these findings...
Research Grants
- Strategies Against HPV Related Genital Diseases in WomenBradley Monk; Fiscal Year: 2006..It is expected that Dr. Monk will have obtained extramural funding for both his laboratory and clinical studies by the end of the period of support requested. ..
- Effect of Oxidant Load on HPV Persistence and CIN (SIL)Anna Giuliano; Fiscal Year: 2007..abstract_text> ..
- Prediction of Pathologic Complete Response by Gene Expression Profiling in EsophaJaffer A Ajani; Fiscal Year: 2010..Our goal is to pave the way for a strategy in the future that will allow administration of effective therapy, improve safety, and preserve the esophagus in some patients. ..
- NATURAL HISTORY OF ANAL NEOPLASIA IN HIV-INFECTED MENJoel Palefsky; Fiscal Year: 1993..These studies may therefore provide valuable information relevant to other diseases as well, such as cancer of the cervix...
- Anal HPV Infection and ASIL in HIV+ and HIV- WomenJoel Palefsky; Fiscal Year: 2006..Knowledge of genes involved in ASIL pathogenesis may provide new approaches to therapy of both anal and cervical HSIL as well as markers for disease progression. ..
- NATURAL HISTORY OF ANAL NEOPLASIA IN HIV INFECTED MENJoel Palefsky; Fiscal Year: 2002....
- Anal HPV Infection and ASIL in HIV+ and HIV- WomenJoel Palefsky; Fiscal Year: 2005..Knowledge of genes involved in ASIL pathogenesis may provide new approaches to therapy of both anal and cervical HSIL as well as markers for disease progression. ..
- Anal Dysplasia in HIV+ and HIV- menTimothy Wilkin; Fiscal Year: 2006..This study will help provide important new information on which groups of HIV+ men may benefit from screening and how HAART may modify this risk. ..
- The Epidemiologic Effects of HAART on HIV-related Anal Cancer and Anal DysplasiaElizabeth Chiao; Fiscal Year: 2007....
- BREAST CANCER AND GENE POLYMORPHISMS IN CHINESE WOMENChu Chen; Fiscal Year: 2003..Our ultimate goal is to provide information to identify women at high risk of breast cancer, and to aid in the formulation of prevention strategies for these women. ..
- MOLECULAR EPIDEMIOLOGY OF LUNG CANCERChu Chen; Fiscal Year: 2010..g. Rosaceae fruits and Cruciferae vegetables), and food-derived nutrients (e.g. carotenoids, vitamin C, and vitamin E). ..
- Natural History of HPV Infection to NeoplasiaAnna Barbara Moscicki; Fiscal Year: 2007..Information garnered from this type of study will be critical in developing vaccine strategies and therapies as well as illuminating immune responses developed in the mucosal epithelium. ..
- Natural History of CIN2 in AdolescentsAnna Barbara Moscicki; Fiscal Year: 2007..S. and specifically assess how best to modify cytology-based screening, utilize HPV diagnostics, and tailor aoDrooriate follow-uo strategies for adolescents and vouna women diaanosed with CIN 2 ..
- Clinical & Cost Effectiveness of HPV Vaccination in the USSue Goldie; Fiscal Year: 2009....
- Breast and Prostate Cancer Patterns of CareRosemary Cress; Fiscal Year: 2007..What is learned about treatment quality and completeness can subsequently be used to improve the information in these registries so that they can become a resource for researchers evaluating quality of cancer care. ..
- Human papillomavirus as a risk factor for HIV infectionPETER CHIN HONG; Fiscal Year: 2007..If HPV-associated epithelial abnormalities are risk factors for HIV infection, then identification of such lesions may improve assessment of HIV transmission risk and could direct future interventions for HIV prevention. ..
- Planning Grant: Cancer Research Training in MoroccoAnna Giuliano; Fiscal Year: 2009..S. and in Morocco, and support cancer that will benefit the U.S. through elucidation of cancer risk factors and cancer disease progression.. ..
- Natural History of HPV Infection in Men: The HIM StudyAnna R Giuliano; Fiscal Year: 2011....
- Cidofovir for Perianal Dysplasia in HIV PatientsElizabeth Stier; Fiscal Year: 2006..Novel treatments, such as topical cidofovir, may prevent pre-cancerous lesions from developing into cancer in HIV-infected patients. ..
- Natural History of HPV Infection in Men: The HIM StudyAnna Giuliano; Fiscal Year: 2007..abstract_text> ..
- Natural History of HPV Infection in Men: The HIM StudyAnna R Giuliano; Fiscal Year: 2010....
- ANTIOXIDANTS NUTRIENTS AMONG A BRAZILIAN POPULATIONAnna Giuliano; Fiscal Year: 2002..Results from this study will efficiently further our understanding of the role of antioxidant nutrients and cervical carcinogens. ..
- FOUR-CORNERS BREAST AND ENDOMETRIAL CANCER STUDYAnna Giuliano; Fiscal Year: 2002..C-peptide, glycosylated hemoglobin, IGF-1, and IGFBP3 will be evaluated with respect to breast and endometrial cancer in a subset of women. ..
- Effect of Oxidant Load on HPV Persistence and CIN (SIL)Anna Giuliano; Fiscal Year: 2004..abstract_text> ..
- HPV methylation: a biomarker of cervical lesion progressAnna Giuliano; Fiscal Year: 2003..Results from this study may provide a novel biomarker for women at risk of progression of HPV infection to SIL. ..
- NATURAL HISTORY OF HPV IN TEENS--INFECTION TO NEOPLASIAAnna Barbara Moscicki; Fiscal Year: 1999..The results from this study will be related to the prevention and education of pre-cancer lesions in young women as well as identifying a clinical model for the role of viruses in abnormal cellular development. ..
- NATURAL HISTORY OF HPV IN TEENS--INFECTION TO NEOPLASIAAnna Barbara Moscicki; Fiscal Year: 1993..The results from this study will be related to the prevention and education of pre-cancer lesions in young women as well as identifying a clinical model for the role of viruses in abnormal cellular development...
- Natural History of CIN2 in AdolescentsAnna Barbara Moscicki; Fiscal Year: 2005..abstract_text> ..
- NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIAAnna Barbara Moscicki; Fiscal Year: 2004..The understanding of both local and systemic immune responses to initial and subsequent HPV infections may be key in vaccine or therapeutic developments. ..
- A San Francisco Street Youth Cohort: At Risk and HIV+Anna Barbara Moscicki; Fiscal Year: 2007..We believe it is critical to continue to engage the high risk youth in the San Francisco Bay Area in clinical and behavioral research. ..
